Journal
ARTHRITIS AND RHEUMATISM
Volume 63, Issue 4, Pages 1044-1053Publisher
WILEY-BLACKWELL
DOI: 10.1002/art.30187
Keywords
-
Categories
Funding
- American College of Rheumatology Research and Education Foundation
- NIH [AR-62277, AR-42460, AI-24717, RR-15577, AR-48940, AR-045084, AR-053483, AR-058554, AI-082714, AI-53747, AI-31584, DE-15223, RR-20143, AI-62629, AR48940, AI-83194, AR-49084, K08-AI-083790, P30-DK-42086, UL1-RR-024999]
- Lupus Clinical Trials Consortium
- US Department of Veterans Affairs
- Alliance for Lupus Research
- Rheuminations, Inc.
- National Institute of Allergy and Infectious Diseases [AI-071651]
- Lupus Research Institute
- Arthritis National Research Foundation
- Genentech
Ask authors/readers for more resources
Objective. Interferon-alpha (IFN alpha) is a primary pathogenic factor in systemic lupus erythematosus (SLE), and high IFN alpha levels may be associated with particular clinical manifestations. The prevalence of individual clinical and serologic features differs significantly by ancestry. This study was undertaken to detect associations between clinical and serologic disease manifestations and serum IFN alpha activity in a large diverse SLE cohort, using multivariate and network analyses. Methods. We studied 1,089 SLE patients (387 African American, 186 Hispanic American, and 516 European American patients). The presence or absence of individual American College of Rheumatology (ACR) clinical criteria for SLE, autoantibodies, and serum IFN alpha activity data were analyzed in univariate and multivariate models. Iterative multivariate logistic regression was performed in each ancestral background group separately to establish the network of associations between variables that were independently significant following Bonferroni correction. Results. In all ancestral backgrounds, high IFN alpha activity was associated with anti-Ro and anti-doublestranded DNA antibodies (P = 4.6 x 10(-18) and P = 2.9 x 10(-16), respectively). Younger age, non-European ancestry, and anti-RNP were also independently associated with increased serum IFN alpha activity (P <= 6.7 x 10(-4)). We found 14 unique associations between variables in network analysis, and only 7 of these associations were shared among > 1 ancestral background. Associations between clinical criteria were different for different ancestral backgrounds, while autoantibody-IFN alpha relationships were similar across backgrounds. IFN alpha activity and autoantibodies were not associated with ACR clinical features in multivariate models. Conclusion. Our findings indicate that serum IFN alpha activity is strongly and consistently associated with autoantibodies, and not independently associated with clinical features in SLE. IFN alpha may be more relevant to humoral tolerance and initial pathogenesis than later clinical disease manifestations.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available